Dr. Eduardo B. Fernandez

  • MD, PhD, FACRO, FASTRO
  • Radiation Oncologist
  • Spoken languages English, Spanish

Overview

Career Positions

Current position(s)

  • GenesisCare - National Medical Director, Plantation, FL

Past position(s)

  • American College of Radiation Oncology - Vice President and Board of Chancellors
  • Aventura Hospital - Chief of Radiation Oncology, Aventura, FL
  • Cleveland Clinic Florida - Head of Radiation Oncology, Dual Appointment at Main Campus of Cleveland Clinic Foundation, Weston, FL

Education

Universities

  • University of Malaga (European Union), PhD, Malaga, Spain
  • University of Malaga (European Union), Doctor of Medicine, Malaga, Spain

Residencies

  • Cleveland Clinic Foundation, Radiation Oncology, Cleveland, OH

Internships

  • Cleveland Clinic Foundation, Medical, Surgical, Cleveland, OH

Expertise And Interests

Interests

  • Prostate, Breast, Lung, Colorectal, Head and Neck, Brain and Spine Tumors

Accomplishments

Awards and honors

  • Multicultural Leadership Award - Florida Diversity Council; Honorary Member of the Radiation Therapy Society of the Dominican Republic; Leader in Medicine Award - Florida Medical Association; Distinguished Physician - Florida Medical Association; Two doct

Publications

  • Protection by Fluoride against Phthalocyanine induced photodynamic killing of Chinese Hamster Cells
  • Comparative Study of Ion F-Mediated Inhibition on Nuclear DNA Photodynamic Damage Induced by Dihematoporphyryn Ether and Chloro-aluminum-phthalocyanine in V-79 Cells
  • Analysis of Toxicity In a Group of Patients Treated for Pancreatic Cancer with Combined Modality 3-D Radiation Therapy
Expand Publications
View 1 more

Presentations

Z120920142

Dioval A. Remonde, BS, Ron R. Allison,MD, Sharon A. Salenius, MPH, Andrej Hnatov, MD, Cynthia Ballenger, MD, Constantine A. Mantz, MD, Eduardo Fernandez,MD,PhD, Steven E. Finkelstein,MD, 2015, ARS

View Presentation

Z120920141

Francisco A. Myslicki, Jesse Shulman, Sharon Salenius, Neal Shore, Constantine Mantz, Eduardo Fernandez, Steven E. Finkelstein, 20158, ARS

View Presentation

Z091420169

Lacombe J, McClain K, Gonzales P, Fernandez E, Galmarini D, Dosoretz D, Zenhausern F, Finkelstein SE., 2016, ACRO

View Presentation

Z091420168

E. Arrojo, E. Fernandez, L. Kestin, A. Martinez., 2016, ACRO

View Presentation

Z091420167

Finkelstein SE, Salenius S, Cross CK, Allison RR, Shafman T, Mantz C, Fernandez E, 2016, ASCO

View Presentation

Z091420162

Finkelstein SE, Forman J, Fernandez E, Chen C, Lieberfarb M, Salenius SA, Shafman T, and Mantz CA, 2016, ASTRO

View Presentation

Z083120151

Martinez A, Olivera G, Ghilezan M, Forman J, Kestin L, Finkelstein S, Mo X, Key S, Mantz C, Fernandez E, Galmarini D, et al., 2015, ASTRO Annual Meeting

View Presentation

Z061520158

Myslicki FA, Salenius SA, Rotterman YW, Mantz CA, Finkelstein SE, Fernandez E., 2015, ACRO Annual Meeting

View Presentation

Z061520154

Allison R, Salenius SA, Hnatov A, Ballenger D, Lichtblau D, Mantz CA, Fernandez E, Finkelstein SE, 2015, ASTRO Annual Meeting

View Presentation

Z061520151

Kestin L, Fernandez E, Mantz C, Olivera G, Mo X, Key S, Finkelstein SE, Martinez A, Galmarini D., 2015, ASTRO Annual Meeting

View Presentation

Z050320162

A. Ahamad, S. Salenius, R. Ross, E. Fernandez, 2016, ASTRO

View Presentation

Z12020161

Anesa W. Ahamad, Sharon Salenius, Chaundre K. Cross, Ron R. Allison, Eduardo B. Fernandez, 2016, ACRO

View Presentation

Z11120172

Mantz Constantine, Wallner Paul, Fernandez Eduardo B., Salenius Sharon, 2017, AAPM Spring Clinical Meeting

View Presentation

Z2920162

Ron R. Allison, Sharon A. Salenius, Andrej Hnatov, Cynthia Ballenger, Anesa Ahamad, Constantine A. Mantz, Eduardo Fernandez, Steven E. Finkelstein, 2016, American Radium Society 100th Anniversary Meeting

View Presentation

Z2920161

Anesa Ahamad, Donald Weed, Darel Pruett, Daniel Saulpaugh, Eduardo Fernandez, 2016, American Radium Society’s 100th Anniversary Meeting

View Presentation

61520157

Myslicki FA, Salenius SA, Shore ND, Mantz CA, Fernandez E, Finkelstein SE, 2015, ACRO Annual Meeting

View Presentation
Expand Presentations
View 14 more

Clinical studies

Primary Objective - To determine whether men with NCCN high risk prostate cancer who are in the lower 2/3 of Decipher genomic risk (< 0.85) can be treated with 12 months ADT plus RT instead of 24 months ADT+RT and experience non-inferior metastasis-free survival.

View Study

Eduardo Fernandez-Vicioso's Reviews

Overall

based on 84 Ratings 20 Comments

2021

His office did very well, and he's very nice and courteous and patient and gentle. And I really like him a lot. And he also put us both at ease about the cancer that I have. Thank you.

2021

I really can not think of anything that could have been done to improve my experience. All of the staff; Dr, Nurses, and Office Staff are exceptionally knowledgeable, caring and professional. I felt more like a family member than a patient, thank you and God Bless you GenesisCare team for all you do!

2021

Dr. Fernández was superb. Make me feel at ease and explained all in a very respectful manner.

2021

I had questions about billing and I was referred to an 800. I called the 800 and they told me to call the office. Both parties I feel were more concerned with who told you to call than what I was asking. I cancelled the treatments until I can better understand the costs of the procedures.

Read More

Ratings and Comments Powered by NRC Health